A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

Clinical trial NCT03082053 · COMPLETED

Trial details

NCT number: NCT03082053
Sponsor: ASLAN Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Biliary Tract Cancer Advanced or Metastatic Solid Tumors

Start date: 2017-01-31
Primary completion: 2017-12-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.